SCHEMBL29544741

SCHEMBL29544741

O=C1NCCn2nc(-c3ccncc3C(F)F)c(Cl)c21

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 2/20 0.36
CDC25B P30305 1/20 0.32
RIPK3 Q9Y572 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29544753 0.80 CCNC (0.36) CDC7
SCHEMBL29544819 0.77 EGFR (0.37)
SCHEMBL29544593 0.76 CDC7 (0.52) CDC7
SCHEMBL31729065 0.76 CDC7 (0.32) CDC7
SCHEMBL29545101 0.74 CSNK1D (0.43)
SCHEMBL29544535 0.73 CDC7 (0.38) CDC7
SCHEMBL29544960 0.71 PARP1 (0.32) CDC7
SCHEMBL29544639 0.71 CDC7 (0.42) CDC7RIPK3
SCHEMBL29545759 0.71 CDC7 (0.42) CDC7RIPK3
SCHEMBL29544807 0.70 HTR2C (0.33) CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 WO disclosed